Metropolitan Life Insurance Company (MetLife)’s Argan AGX Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio AGX Stock Details AGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-757	Closed	-$38.3K	–	68
2024 Q1	$38.3K	Hold	757	–	–	﹤0.01%	1543
2023 Q4	$35.4K	Hold	757	–	–	﹤0.01%	1624
2023 Q3	$34.5K	Hold	757	–	–	﹤0.01%	1604
2023 Q2	$29.8K	Hold	757	–	–	﹤0.01%	1718
2023 Q1	$30.6K	Hold	757	–	–	﹤0.01%	1675
2022 Q4	$27.9K	Hold	757	–	–	﹤0.01%	1825
2022 Q3	$24.4K	Hold	757	–	–	﹤0.01%	1920
2022 Q2	$28.3K	Sell	757 -289	-28%	-$11.1K	﹤0.01%	1857
2022 Q1	$42.5K	Sell	1,046 -2,793	-73%	-$109K	﹤0.01%	1686
2021 Q4	$149K	Hold	3,839	–	–	﹤0.01%	2229
2021 Q3	$168K	Sell	3,839 -1,074	-22%	-$48.6K	﹤0.01%	2207
2021 Q2	$235K	Buy	4,913 +296	+6%	+$14.7K	﹤0.01%	2029
2021 Q1	$246K	Sell	4,617 -293	-6%	-$14.1K	﹤0.01%	1869
2020 Q4	$218K	Hold	4,910	–	–	﹤0.01%	1879
2020 Q3	$206K	Hold	4,910	–	–	﹤0.01%	1752
2020 Q2	$233K	Hold	4,910	–	–	﹤0.01%	1697
2020 Q1	$170K	Hold	4,910	–	–	﹤0.01%	1683
2019 Q4	$197K	Hold	4,910	–	–	﹤0.01%	1942
2019 Q3	$193K	Hold	4,910	–	–	﹤0.01%	1899
2019 Q2	$199K	Hold	4,910	–	–	﹤0.01%	1893
2019 Q1	$245K	Hold	4,910	–	–	﹤0.01%	1766
2018 Q4	$186K	Hold	4,910	–	–	﹤0.01%	1870
2018 Q3	$211K	Hold	4,910	–	–	﹤0.01%	1977
2018 Q2	$201K	Sell	4,910 -3,867	-44%	-$151K	﹤0.01%	1941
2018 Q1	$377K	Buy	8,777 +4,069	+86%	+$171K	0.01%	1464
2017 Q4	$212K	Sell	4,708 -4,562	-49%	-$272K	﹤0.01%	1880
2017 Q3	$623K	Hold	9,270	–	–	﹤0.01%	1536
2017 Q2	$556K	Buy	9,270 +402	+5%	+$26K	﹤0.01%	1611
2017 Q1	$587K	Hold	8,868	–	–	﹤0.01%	1547
2016 Q4	$626K	Sell	8,868 -618	-7%	-$38.6K	﹤0.01%	1588
2016 Q3	$561K	Sell	9,486 -29	-0.3%	-$1.42K	﹤0.01%	1635
2016 Q2	$397K	Hold	9,515	–	–	﹤0.01%	1847
2016 Q1	$335K	Hold	9,515	–	–	﹤0.01%	1827
2015 Q4	$308K	Hold	9,515	–	–	﹤0.01%	1943
2015 Q3	$330K	Hold	9,515	–	–	﹤0.01%	1916
2015 Q2	$384K	Sell	9,515 -718	-7%	-$25.7K	﹤0.01%	1933
2015 Q1	$370K	Hold	10,233	–	–	﹤0.01%	1723
2014 Q4	$344K	Hold	10,233	–	–	﹤0.01%	2034
2014 Q3	$342K	Hold	10,233	–	–	﹤0.01%	1978
2014 Q2	$382K	Hold	10,233	–	–	﹤0.01%	2037
2014 Q1	$304K	Sell	10,233 -3,127	-23%	-$90K	﹤0.01%	2158
2013 Q4	$368K	Buy	13,360 +4,811	+56%	+$113K	﹤0.01%	2027
2013 Q3	$188K	Hold	8,549	–	–	﹤0.01%	2469
2013 Q2	$133K	Buy	+8,549	New	+$140K	﹤0.01%	2617

Other funds holding AGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s AGX Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Argan (AGX) in Q2 2024, closing a stake of 757 shares — an estimated $38.3K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in AGX in Q2 2013 and held it in 44 quarters. The position peaked at $626K in Q4 2016. 205 funds tracked by Wall St. Rank hold AGX as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Argan position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 757 Argan shares in Q2 2024, an estimated $38.3K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Argan in Q2 2013 and held it in 44 quarters.
Metropolitan Life Insurance Company (MetLife)'s Argan position peaked at $626K in Q4 2016.
205 funds tracked by Wall St. Rank held Argan as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.